Comparative analysis of the antiretroviral activity of APOBEC3G and APOBEC3F from primates (Q28295787)

From Wikidata

Jump to navigation Jump to search

The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

scientific article

Language	Label	Description	Also known as
English	Comparative analysis of the antiretroviral activity of APOBEC3G and APOBEC3F from primates	scientific article

Statements

scholarly article

0 references

Comparative analysis of the antiretroviral activity of APOBEC3G and APOBEC3F from primates (English)

0 references

anti-retroviral agent

0 references

2

object named as

Paul D Bieniasz

0 references

author name string

Véronique Zennou

1

0 references

language of work or name

0 references

publication date

25 May 2006

0 references

0 references

349

0 references

1

0 references

31-40

0 references

APOBEC3G is incorporated into virus-like particles by a direct interaction with HIV-1 Gag nucleocapsid protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.035

7 January 2021

Cytidine deamination of retroviral DNA by diverse APOBEC proteins

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.035

7 January 2021

A single amino acid difference in the host APOBEC3G protein controls the primate species specificity of HIV type 1 virion infectivity factor

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.035

7 January 2021

The interaction between HIV-1 Gag and APOBEC3G.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.035

7 January 2021

The Vif Protein of HIV Triggers Degradation of the Human Antiretroviral DNA Deaminase APOBEC3G

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.035

7 January 2021

Sensitivity of human immunodeficiency virus type 1 to the fusion inhibitor T-20 is modulated by coreceptor specificity defined by the V3 loop of gp120

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.035

7 January 2021

Human APOBEC3B is a potent inhibitor of HIV-1 infectivity and is resistant to HIV-1 Vif.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.035

7 January 2021

Differential sensitivity of murine leukemia virus to APOBEC3-mediated inhibition is governed by virion exclusion

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.035

7 January 2021

HIV-1 and MLV Gag proteins are sufficient to recruit APOBEC3G into virus-like particles

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.035

7 January 2021

DNA deamination mediates innate immunity to retroviral infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.035

7 January 2021

The human immunodeficiency virus type 1 Vif protein reduces intracellular expression and inhibits packaging of APOBEC3G (CEM15), a cellular inhibitor of virus infectivity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.035

7 January 2021

Viral RNA is required for the association of APOBEC3G with human immunodeficiency virus type 1 nucleoprotein complexes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.035

7 January 2021

Hypermutation of HIV-1 DNA in the Absence of the Vif Protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.035

7 January 2021

APOBEC3F properties and hypermutation preferences indicate activity against HIV-1 in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.035

7 January 2021

Influence of primate lentiviral Vif and proteasome inhibitors on human immunodeficiency virus type 1 virion packaging of APOBEC3G.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.035

7 January 2021

Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.035

7 January 2021

A single amino acid determinant governs the species-specific sensitivity of APOBEC3G to Vif action

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.035

7 January 2021

Species-specific exclusion of APOBEC3G from HIV-1 virions by Vif

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.035

7 January 2021

HIV-1 Vif protein binds the editing enzyme APOBEC3G and induces its degradation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.035

7 January 2021

HIV-1 and Ebola virus encode small peptide motifs that recruit Tsg101 to sites of particle assembly to facilitate egress

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.035

7 January 2021

Vif overcomes the innate antiviral activity of APOBEC3G by promoting its degradation in the ubiquitin-proteasome pathway

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.035

7 January 2021

Antiviral function of APOBEC3G can be dissociated from cytidine deaminase activity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.035

7 January 2021

Detecting hypermutations in viral sequences with an emphasis on G --> A hypermutation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.035

7 January 2021

Specific packaging of APOBEC3G into HIV-1 virions is mediated by the nucleocapsid domain of the gag polyprotein precursor

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.035

7 January 2021

A single amino acid of APOBEC3G controls its species-specific interaction with virion infectivity factor (Vif).

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.035

7 January 2021

Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.035

7 January 2021

The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.035

7 January 2021

HIV-1 Vif Blocks the Antiviral Activity of APOBEC3G by Impairing Both Its Translation and Intracellular Stability

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.035

7 January 2021

Human apolipoprotein B mRNA-editing enzyme-catalytic polypeptide-like 3G (APOBEC3G) is incorporated into HIV-1 virions through interactions with viral and nonviral RNAs.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.035

7 January 2021

A second human antiretroviral factor, APOBEC3F, is suppressed by the HIV-1 and HIV-2 Vif proteins

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.035

7 January 2021

A single amino acid substitution in human APOBEC3G antiretroviral enzyme confers resistance to HIV-1 virion infectivity factor-induced depletion

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.035

7 January 2021

Induction of APOBEC3G Ubiquitination and Degradation by an HIV-1 Vif-Cul5-SCF Complex

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.035

7 January 2021

APOBEC3B and APOBEC3C are potent inhibitors of simian immunodeficiency virus replication

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.035

7 January 2021

Single-strand specificity of APOBEC3G accounts for minus-strand deamination of the HIV genome

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.035

7 January 2021

APOBEC3G incorporation into human immunodeficiency virus type 1 particles

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.035

7 January 2021

The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.035

7 January 2021

Human APOBEC3F is another host factor that blocks human immunodeficiency virus type 1 replication

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.035

7 January 2021

Identifiers

10.1016/J.VIROL.2005.12.035

0 references

PubMed publication ID

0 references

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28295787&oldid=1953875887"